Ginsenoside Rb1 also enhanced the phagocytic capacity of macrophages for bacteria via activation of the p38/Akt pathway, which may be a useful pharmacological adjuvant for the treatment of bacterial infections in clinically relevant conditions (Xin et al., 2019). The gene discussed is AKT1; the disease is bacterial infectious disease.